Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.

导出 OA

翻译打印收藏纠错

第一作者： Gregory G,Schwartz

第一单位： Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA. Electronic address: gregory.schwartz@cuanschutz.edu.

作者： Gregory G,Schwartz ^[1] ; Michael,Szarek ^[2] ; Vera A,Bittner ^[3] ; Rafael,Diaz ^[4] ; Shaun G,Goodman ^[5] ; J Wouter,Jukema ^[6] ; Ulf,Landmesser ^[7] ; Patricio,López-Jaramillo ^[8] ; Garen,Manvelian ^[9] ; Robert,Pordy ^[9] ; Michel,Scemama ^[10] ; Peter R,Sinnaeve ^[11] ; Harvey D,White ^[12] ; Ph,Gabriel Steg ^[13] ; ODYSSEY Outcomes Committees and Investigators

作者单位： Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA. Electronic address: gregory.schwartz@cuanschutz.edu. ^[1] State University of New York, Downstate School of Public Health, Brooklyn, New York, USA; CPC Clinical Research and Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA. ^[2] Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA. ^[3] Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina. ^[4] Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada; St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. ^[5] Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands; Netherlands Heart Institute, Utrecht, the Netherlands. ^[6] Department of Cardiology, Charité Universitätsmedizin Berlin, Berlin, Germany. ^[7] Masira Research Institute, Medical School (UDES), Bucaramanga, Colombia. ^[8] Regeneron Pharmaceuticals, Tarrytown, New York, USA. ^[9] Sanofi, Paris, France. ^[10] Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium. ^[11] Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand. ^[12] Université de Paris, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, French Alliance for Cardiovascular Trials, and INSERM U1148, Paris, France; Imperial College, Royal Brompton Hospital, London, United Kingdom. Electronic address: https://twitter.com/gabrielsteg. ^[13]

关键词 PCSK9 inhibitor acute coronary syndrome lipoprotein(a)low-density lipoprotein cholesterol